Egg Rejuvenation Therapeutic 1
Improvement of IVF success rates (age-related egg quality decline)
PreclinicalActive
Key Facts
Indication
Improvement of IVF success rates (age-related egg quality decline)
Phase
Preclinical
Status
Active
Company
About Ovo Labs
Ovo Labs is a preclinical-stage biotech developing 'egg rejuvenation' therapeutics to address the primary reason for IVF failure: chromosomal errors in aging eggs. Founded by world-leading reproductive scientists and clinicians, the company aims to boost IVF success rates by 20-30% for women under 35 and by 3-5 times for women aged 35-45. With a strong academic foundation and a leadership team combining deep scientific expertise with business strategy, Ovo Labs is positioned to tackle a significant unmet need in the large and growing global fertility market.
View full company profileTherapeutic Areas
Other Improvement of IVF success rates (age-related egg quality decline) Drugs
| Drug | Company | Phase |
|---|---|---|
| Egg Rejuvenation Therapeutic 2 | Ovo Labs | Preclinical |
| Egg Rejuvenation Therapeutic 3 | Ovo Labs | Preclinical |